Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

582.65INR
10:27am IST
Change (% chg)

Rs-0.90 (-0.15%)
Prev Close
Rs583.55
Open
Rs585.95
Day's High
Rs587.95
Day's Low
Rs578.85
Volume
390,945
Avg. Vol
2,290,411
52-wk High
Rs809.45
52-wk Low
Rs527.00

Chart for

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.63
Market Cap(Mil.): Rs352,675.50
Shares Outstanding(Mil.): 585.91
Dividend: 1.00
Yield (%): 0.44

Financials

  ARBN.NS Industry Sector
P/E (TTM): 13.82 29.21 33.15
EPS (TTM): 41.36 -- --
ROI: 21.98 13.66 13.23
ROE: 23.02 15.51 15.27

BUZZ-Apotex deal to help India's Aurobindo Pharma deepen EU presence - Citi

** Citi says Aurobindo Pharma Ltd's 74 mln euros ($86.6 mln) deal to buy some European businesses of Canadian firm Apotex International Ltd is part of inorganic strategy

16 Jul 2018

BUZZ-India's Aurobindo Pharma slips on Q4 miss

** Aurobindo Pharma Ltd plunges as much as 6.2 pct to 567.95 rupees, its lowest in a week

29 May 2018

Aurobindo Pharma fourth-quarter profit misses estimates

India's Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts' estimates.

28 May 2018

India's Aurobindo Pharma Q4 profit misses estimates

May 28 India's Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts' estimates.

28 May 2018

MEDIA-India's Aurobindo Pharma eyes Mallinckrodt Opioids again - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

23 May 2018

BRIEF-Aurobindo Pharma Says U.S. FDA Issued Form 483 With 9 Observations for Co's Unit

* AUROBINDO PHARMA LTD CLARIFIES ON NEWS ITEM ON CO'S UNIT 4 GETTING 9 OBSERVATIONS AFTER U.S. FDA INSPECTION

05 Mar 2018

BUZZ-India's Aurobindo Pharma falls; USFDA cites quality issues at unit - report

** Drugmaker Aurobindo Pharma Ltd falls as much as 5.5 pct to 590 rupees, its lowest since Feb 23

05 Mar 2018

MEDIA-India's Aurobindo Pharma eyes European business of Apotex - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

21 Feb 2018

BRIEF-Aurobindo Pharma Says Approved Dividend Of 1 Rupee Per Share

* SAYS APPROVED SECOND INTERIM DIVIDEND OF 1 RUPEE PER SHARE Source text for Eikon: Further company coverage:

07 Feb 2018

Aurobindo Pharma Q3 profit up about 3 pct, misses estimates

Feb 7 Aurobindo Pharma Ltd, India's third largest drugmaker by revenue, posted an about 3 percent rise in quarterly profit on Wednesday, but missed analysts' estimates.

07 Feb 2018

Earnings vs. Estimates